Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents

Abstract

We found a nearly 3-fold increased risk of cancer in biologics-naive JIA patients, which approached significance despite the small number of outcomes. This finding suggests an elevated underlying risk of cancer in this disease population.